高级搜索
增殖细胞核抗原与p55PIK结合调控乳腺癌细胞MCF7增殖的研究[J]. 肿瘤防治研究, 2015, 42(01): 9-13. DOI: 10.3971/j.issn.1000-8578.2015.01.003
引用本文: 增殖细胞核抗原与p55PIK结合调控乳腺癌细胞MCF7增殖的研究[J]. 肿瘤防治研究, 2015, 42(01): 9-13. DOI: 10.3971/j.issn.1000-8578.2015.01.003
p55PIK Combined with Proliferating Cell Nuclear Antigen Promote Proliferation of Breast Cancer Cells MCF7[J]. Cancer Research on Prevention and Treatment, 2015, 42(01): 9-13. DOI: 10.3971/j.issn.1000-8578.2015.01.003
Citation: p55PIK Combined with Proliferating Cell Nuclear Antigen Promote Proliferation of Breast Cancer Cells MCF7[J]. Cancer Research on Prevention and Treatment, 2015, 42(01): 9-13. DOI: 10.3971/j.issn.1000-8578.2015.01.003

增殖细胞核抗原与p55PIK结合调控乳腺癌细胞MCF7增殖的研究

p55PIK Combined with Proliferating Cell Nuclear Antigen Promote Proliferation of Breast Cancer Cells MCF7

  • 摘要: 目的 观察p55PIK对乳腺癌细胞MCF7细胞周期及增殖的影响,并探讨其可能的机制。方法 通过转染质粒或特异性siRNA,在乳腺癌MCF7细胞中过表达或低表达p55PIK,继而通过免疫印迹法检测p55PIK的表达,通过BrdU/PI双掺入法测定细胞DNA合成及细胞周期,并用CCK-8(cellcounting kit-8)试剂盒检测细胞增殖,最后通过免疫共沉淀技术检测明确p55PIK是否可以与增殖细胞核抗原(proliferating cell nuclear antigen,PCNA)相结合。 结果 p55PIK过表达质粒及siRNA可分别使MCF7细胞中p55PIK成功过表达或低表达,而且过表达p55PIK可加快MCF7细胞的DNA合成,p55PIK组DNA合成比率为(56.33±1.63)%与Vector组DNA合成比率为(26.27±1.85)%比较差异有统计学意义(P<0.01),过表达5PIK促进MCF7细胞从G0/G1期进入S期,从而调节其增殖,p55PIK组OD450nm:(1.46±0.04)与Vector组OD450nm:(1.16±0.16)比较差异有统计学意义(P<0.05),而低表达p55PIK可抑制上述过程。免疫共沉淀证实p55PIK与PCNA之间可以相结合。 结论 p55PIK可促进乳腺癌细胞MCF7细胞周期进程及增殖,而且p55PIK可与PCNA相结合。

     

    Abstract: Objective To investigate the effect of p55PIK on cell cycle and proliferation of breast cancer cells MCF7, and the potential mechanism. Methods Breast cancer cells MCF7 were transfected with plasmids or specific siRNA for over-expression or low-expression of p55PIK. Then p55PIK expression was detected by Western blot. Cell cycle and DNA synthesis were measured through BrdU/PI. Meanwhile, Cell Counting Kit-8(CCK-8) assay was performed to detect the proliferation of breast cancer cells MCF7, and a co-immunoprecipitation assay was conducted to find out whether p55PIK could bind with proliferating cell nuclear antigen(PCNA). Results p55PIK was successfully up-regulated or down-regulated after transfection. p55PIK overexpression could promote DNA synthesis and the proliferation of breast cancer MCF7 cells DNA synthesis by BrdU: p55PIK vs. Vector, (56.33±1.63)% vs. (26.27±1.85)%, P<0.01; CCK-8 at OD450nm: p55PIK vs. Vector, (1.46±0.04) vs. (1.16±0.16), P<0.05). Meanwhile, down-regulation of p55PIK could inhibit cell cycle and the proliferation of breast cancer cells MCF7. p55PIK could combine with PCNA. Conclusion p55PIK could promote cell cycle progress and the proliferation of breast cancer cells MCF7. Moreover, p55PIK could combine with PCNA.

     

/

返回文章
返回